BACKGROUND: To examine cross-sectional differences and longitudinal changes in cognitive performance based on the presence of mild behavioral impairment (MBI) among older adults who are cognitively healthy or have mild cognitive impairment (MCI). METHODS: Secondary data analysis of participants (n = 17 291) who were cognitively healthy (n = 11 771) or diagnosed with MCI (n = 5 520) from the National Alzheimer's Coordinating Center database. Overall, 24.7% of the sample met the criteria for MBI. Cognition was examined through a neuropsychological battery that assessed attention, episodic memory, executive function, language, visuospatial ability, and processing speed. RESULTS: Older adults with MBI, regardless of whether they were cognitively healthy or diagnosed with MCI, performed significantly worse at baseline on tasks for attention, episodic memory, executive function, language, and processing speed and exhibited greater longitudinal declines on tasks of attention, episodic memory, language, and processing speed. Cognitively healthy older adults with MBI performed significantly worse than those who were cognitively healthy without MBI on tasks of visuospatial ability at baseline and on tasks of processing speed across time. Older adults with MCI and MBI performed significantly worse than those with only MCI on executive function at baseline and visuospatial ability and processing speed tasks across time. CONCLUSIONS: This study found evidence that MBI is related to poorer cognitive performance cross-sectionally and longitudinally. Additionally, those with MBI and MCI performed worse across multiple tasks of cognition both cross-sectionally and across time. These results provide support for MBI being uniquely associated with different aspects of cognition.

Department of Neurology Charles University Prague Czech Republic

Department of Psychiatry Clinical Neurosciences and Community Health Sciences University of Calgary Calgary Alberta Canada

Edson College of Nursing and Health Innovation Arizona State University Phoenix Arizona USA

Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada

School of Aging Studies University of South Florida Tampa Florida USA

Zobrazit více v PubMed

Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17:327–406. doi:10.1002/alz.12328 PubMed DOI

Bäckman  L, Jones  S, Berger  A, Laukka  E, Small  B.  Cognitive impairment in preclinical Alzheimer’s disease: a meta-analysis. Neuropsychology.  2005;19(4):520–531. doi:10.1037/0894-4105.19.4.520 PubMed DOI

Jack  C, Knopman  D, Jagust  W, et al. . Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol.  2013;12(2):207–216. doi:10.1016/S1474-4422(12)70291-0 PubMed DOI PMC

Montero-Odasso  M, Pieruccini-Faria  F, Ismail  Z, et al. . CCCDTD5 recommendations on early non cognitive markers of dementia: a Canadian consensus. Alzheimers Dement: TRCI. 2020;6:1–18. doi:10.1002/trc2.12068 PubMed DOI PMC

Mortby  M, Burns  R, Eramudugolla  R, Ismail  Z, Anstey  K.  Neuropsychiatric symptoms and cognitive impairment: understanding the importance of co-morbid symptoms. J Alzheimers Dis.  2017;59(1):141–153. doi:10.3233/JAD-170050 PubMed DOI

Wise  E, Rosenberg  P, Lyketsos  C, Leoutsakos  J.  Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer’s Coordinating Centers volunteers. Alzheimers Dement (Amst). 2019;11:333–339. doi:10.1016/j.dadm.2019.02.006 PubMed DOI PMC

Burhanullah  M, Tschanz  J, Peters  M, et al. . Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: the Cache County Study. Am J Geriatr Psychiatry. 2020;28(1):64–71. doi:10.1016/j.jagp.2019.03.023 PubMed DOI PMC

Ismail  Z, Agüera-Ortiz  L, Brodaty  H, et al. . The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis.  2016;56(3):929–938. doi:10.3233/JAD-160979 PubMed DOI PMC

Ismail  Z, McGirr  A, Gill  S, Hu  S, Forkert  N, Smith  E.  Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline. J Alzheimers Dis.  2021;80:459–469. doi:10.3233/JAD-201184 PubMed DOI PMC

Matsuoka  T, Ismail  Z, Narumoto  J.  Prevalence of mild behavioral impairment and risk of dementia in a psychiatric outpatient clinic. J Alzheimers Dis.  2019;70(2):505–513. doi:10.3233/JAD-190278 PubMed DOI PMC

Taragano  F, Allegri  R, Krupitzki  H, et al. . Mild behavioral impairment and risk of dementia. J Clin Psychiatry.  2009;70(4):584–592. doi:10.4088/JCP.08m04181 PubMed DOI PMC

Taragano  F, Allegri  R, Heisecke  S, et al. . Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis. 2018;62(1):227–238. doi:10.3233/JAD-170632 PubMed DOI

Creese  B, Brooker  H, Ismail  Z, et al. . Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry.  2019;27(8):823–834. doi:10.1016/j.jagp.2019.01.215 PubMed DOI

Kassam  F, Chen  H, Nosheny  R, et al. . Cognitive profile of people with mild behavioral impairment in Brain Health Registry participants. Int Pscyhogeriatr. 2022:1–10. doi:10.1017/S1041610221002878 PubMed DOI PMC

Rouse  H, Small  B, Schinka  J, Loewenstein  D, Duara  R, Potter  H.  Mild behavioral impairment as a predictor of cognitive functioning in older adults. Int Psychogeriatr.  2021;33(3):285–293. doi:10.1017/S1041610220000678 PubMed DOI

Morris  J, Weintraub  S, Chui  H, et al. . The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord.  2006;20(4):210–216. doi:10.1097/01.wad.0000213865.09806.92 PubMed DOI

Beekly  D, Ramos  E, Belle  G, et al. . The National Alzheimer’s Coordinating Center (NACC) database: an Alzheimer disease database. Alzheimer Dis Assoc Disord.  2004;18(4):270–277. PubMed

Beekly  D, Ramos  E, Lee  W, et al. . The National Alzheimer’s Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord.  2007;21(3):249–258. doi:10.1097/WAD.0b013e318142774e PubMed DOI

Besser  L, Kukull  W, Knopman  D, et al. . Version 3 of the National Alzheimer’s coordinating center’s Uniform Data Set. Alzheimer Dis Assoc Disord.  2018;32(4):351–358. doi:10.1097/WAD.0000000000000279 PubMed DOI PMC

Weintraub  S, Besser  L, Dodge  H, et al. . Version 3 of the Alzheimer Disease Centers’ neuropsychological test battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord. 2018;32(1):10–17. doi:10.1097/WAD.0000000000000223 PubMed DOI PMC

Cummings  J.  The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology.  1997;48(5):S10–S16. doi:10.1212/wnl.48.5_suppl_6.10s PubMed DOI

Kaufer  D, Cummings  J, Ketchel  P, et al. . Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci.  2000;12(2):233–239. doi:10.1176/jnp.12.2.233 PubMed DOI

Gill  S, Mouches  P, Hu  S, et al. . Using machine learning to predict dementia from neuropsychiatric symptom and neuroimaging data. J Alzheimers Dis.  2020;75(1):277–288. doi:10.3233/JAD-191169 PubMed DOI PMC

Petersen  R, Smith  G, Waring  S, Ivnik  R, Tangalos  E, Kokmen  E.  Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308. doi:10.1001/archneur.56.3.303 PubMed DOI

Weintraub  S, Salmon  D, Mercaldo  N, et al. . The Alzheimer’s Disease Centers’ Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord.  2009;23(2):91–101. doi:10.1097/WAD.0b013e318191c7dd PubMed DOI PMC

Monsell  S, Dodge  H, Zhou  X, et al. . Results from the NACC Uniform Data Set neuropsychological battery crosswalk study. Alzheimer Dis Assoc Disord.  2016;30(2):134–139. doi:10.1097/WAD.0000000000000111 PubMed DOI PMC

Nasreddine  Z, Phillips  N, Bedirian  V, et al. . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc.  2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x PubMed DOI

Folstein  M, Folstein  S, McHugh  P.  “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.  1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6 PubMed DOI

Wechsler  D. Wechsler Memory Scale-Revised Manual. Psychological Corporation; 1987.

Reitan  R, Wolfson  D.. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 2nd ed. Neuropsychogy Press; 1993.

Gollan  T, Salmon  D, Montoya  R, Galasko  D.  Degree of bilingualism predicts age of diagnosis of Alzheimer’s disease in low-education but not in highly educated Hispanics. Neuropsychologia.  2011;49(14):3826–3830. doi:10.1016/j.neuropsychologia.2011.09.041 PubMed DOI PMC

Ivanova  I, Salmon  D, Gollan  T.  The multilingual naming test in Alzheimer’s disease: clues to the origin of naming impairments. J Int Neuropsychol Soc.  2013;19(3):272–283. doi:10.1017/S1355617712001282 PubMed DOI PMC

Goodglass  H, Kaplan  E, Baressi  B.. Boston Diagnostic Aphasia Examination. 3rd ed. Lippincott Williams & Wilkins; 2001

Kaplan  E, Goodglass  H, Weintraub  S.. The Boston Naming Test. 2nd ed. Lea and Febige; 2001.

Lucas  J, Ivnik  R, Smith  G, et al. . Mayo’s older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol.  1998;20(2):194–200. doi:10.1076/jcen.20.2.194.1173 PubMed DOI

Morris  J, Heyman  A, Mohs  R, et al. . The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer’s disease. Neurology.  1989;39(9):1159–1159. doi:10.1212/WNL.39.9.1159 PubMed DOI

Ivnik  R, Malec  J, Smith  G, Tangalos  E, Petersen  R.  Neuropsychological tests’ norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol.  1996;10(2):262–278. doi:10.1080/13854049608406689 DOI

Craft  S, Asthana  S, Schellenberg  G, et al. . Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer’s disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci.  2000;903:222–228. doi:10.1111/j.1749-6632.2000.tb06371.x PubMed DOI

Craft  S, Newcomer  J, Kanne  S, et al. . Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Aging.  1966;17(1):123–130. doi:10.1016/0197-4580(95)02002-0 PubMed DOI

Possin  K, Laluz  V, Alcantar  O, Miller  B, Kramer  J.  Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer’s disease and behavioral variant frontotemporal dementia. Neuropsychologia.  2011;49(1):43–48. doi:10.1016/j.neuropsychologia.2010.10.026 PubMed DOI PMC

Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Routledge Academic; 1988.

David  N, Lin  F, Porsteinsson  A.  Trajectories of neuropsychiatric symptoms and cognitive decline in mild cognitive impairment. Am J Geriatr Psychiatry. 2016;24(1):70–80. doi:10.1016/j.jagp.2015.06.001 PubMed DOI PMC

Norman  G, Sloan  J, Wyrwich  K.  Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care.  2003;41(5):582–592. doi:10.1097/01.MLR.0000062554.74615.4C PubMed DOI

Wolfova  K, Creese  B, Aarsland  D, et al. . Sex differences in the association of mild behavioral impairment with cognitive aging. J Alzheimers Dis.  2022;88(1):345–355. doi:10.3233/JAD-220040 PubMed DOI